Targeting EGFR Exon 20 Insertions in Non–small Cell Lung Cancer: Recent Advances and Clinical Updates

The authors describe the molecular and clinicopathologic features of EGFR ins20 mutations and summarize recent data on emerging therapies for patients with this subtype of EGFR-mutant non–small cell lung cancer (NSCLC).